跳至主要内容
临床试验/NCT03431506
NCT03431506Unknown不适用

Vestibular Function and Vestibular Rehabilitation in Sudden Sensorneural Hearing Loss With Vertigo

Eye & ENT Hospital of Fudan University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年12月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
Assessment of vestibular function status by vestibular function tests in SSHL with vertigo at stage 1(before treatment)

研究概览

简要总结

To evaluate the vestibular function and vestibular rehabilitation in sudden sensorneural hearing loss(SSHL) with vertigo

详细描述

Approximately 5-20 per 100,000 persons are afflicted with SSHL annually, and nearly 20-60% of SSHL patients complain of simultaneous vertigo.The aim of this study was to evaluate the prevalence of vestibulocochlear lesions in sudden sensorneural hearing loss(SSHL) with vertigo, as well as the role of vestibular rehabilitation in the prognosis of SSHL with vertigo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double (Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • A rapid onset sensorineural hearing loss of more than 30 dB for at least three contiguous audiometric frequencies within a period of 3 days, according to standard AAO - HNS;
  • Within 10 days from onset;
  • Without other virus infectious disease within three months.

排除标准

  • BPPV; Meniere's disease and vestibular migraine.
  • With certain Known etiology, including acoustic neuroma, heart cerebrovascular accident, injury, Hunt syndrome, etc

结局指标

主要结局

Assessment of vestibular function status by vestibular function tests in SSHL with vertigo at stage 1(before treatment)

时间窗: before treatment

Vestibular function status in SSHL with vertigo at stage 1(before treatment)

次要结局

  • Assessment of vestibular function status by vestibular function tests in SSHL with vertigo at stage 2(2 weeks after treatment)(2 weeks after treatment)
  • Assessment of vestibular function status by vestibular function tests in SSHL with vertigo at stage 2(2 months after treatment)(2 months after treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验